Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R. S. Rud'"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 734-741 (2023)
The modern cardiology has a wide range of medications which affect various pathogenetic links of atherosclerosis, but even the best of them still obtain disadvantages causing intolerance and medicine discontinuation. The development of new hypolipide
Externí odkaz:
https://doaj.org/article/abe4cbf6267744ecb22be37a9dc15e6c
Autor:
R. S. Rud, O. V. Blagova, E. A. Kogan, V. M. Novosadov, A. Yu. Zaitsev, V. P. Sedov, V. A. Zaydenov, A. G. Kupriyanova, V. V. Kadochnikova, A. E. Donnikov, A. V. Nedostup
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 11 (2021)
Aim. To study the efficacy and safety of mycophenolate mofetil (MM) in combination with corticosteroids in the treatment of lymphocytic myocarditis in comparison with a standard combination of corticosteroids and azathioprine.Material and methods. Th
Externí odkaz:
https://doaj.org/article/35c7f2bc2f634f0694f6490c7db49d39
Autor:
Olga Blagova, V M Novosadov, Svetlana Alexandrova, V V Fomin, A G Kupriyanova, Yu A Lutokhina, V A Zaidenov, D H Ainetdinova, R S Rud, A Yu Zaitsev, A D Kukleva, E A Kogan
Publikováno v:
Kardiologiia. 61:11-27
Aim To study clinical features of myoendocarditis and its possible mechanisms, including persistence of SARS-Cov-2 in the myocardium, in the long-term period following COVID-19.Material and methods This cohort, prospective study included 15 patients
Publikováno v:
European Heart Journal. 42
Purpose To compare of the efficacy and safety of mycophenolate mofetil (MM) and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis. Methods The study included 45 patients with lymphocytic myocarditis, 34 male
Autor:
Alexander Zaitsev, D H Ainetdinova, S A Alexandrova, V M Novosadov, Olga Blagova, Yulia Lutokhina, E A Kogan, R S Rud, A D Kukleva
Publikováno v:
European Heart Journal. 42
Purpose To study clinical features of myocarditis and its possible mechanisms (including persistence of SARS-Cov-2 in the myocardium) in the long-term period after acute COVID-19. Methods Fifteen patients (8 male and 7 female, mean age 47.8±13.4, 24